Pricing Log in Create free account

Aligos Therapeutics, Inc. (ALGS) vs Polyrizon Ltd. (PLRZ)

Aligos Therapeutics, Inc. and Polyrizon Ltd. are both Biotechnology companies. Aligos Therapeutics, Inc. and Polyrizon Ltd. are of similar size ($28.2M and $27.5M). Across the 8 metrics below, Polyrizon Ltd. leads on 7 and Aligos Therapeutics, Inc. on 1.

Valuation

Metric ALGS PLRZ Biotechnology median
P/E n/m — 10.60
P/S 1.27 — 9.40
P/B 3.78 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 0.37 n/m 9.02
Earnings yield (155.26%) — (32.88%)
Free cash flow yield (160.62%) 0.00% (23.13%)

Profitability

Metric ALGS PLRZ Biotechnology median
Gross margin 100.00% — 68.51%
Operating margin (215.55%) — 0.00%
Net margin (197.01%) — 0.00%
Free cash flow margin (203.21%) 0.00% 0.00%
Return on equity (159.46%) 0.00% (51.96%)
Return on assets (84.46%) 0.00% (46.06%)
Return on invested capital (400.91%) 0.00% 0.00%

Growth

Metric ALGS PLRZ Biotechnology median
Revenue growth (TTM) 1,171.58% — 6.76%
EPS growth (last fiscal year) 88.30% 99.39% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ALGS PLRZ Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.77 36.37 4.97
Net debt to EBITDA 0.87 2.11 1.01

Dividend

Metric ALGS PLRZ Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ALGS PLRZ Biotechnology median
Market cap 28.17m 27.49m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack